Tweenvest Stocks

MAIA Biotechnology, Inc. (NYSEAM: MAIA)

Health Care · Biotechnology · US

$1.15

-3.36% today · -31.2% 1Y

MAIA Biotechnology, Inc. (NYSEAM: MAIA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $72.38M and employs 13 people.

Over the last twelve months the share price has lost 31.2%, trading between 0.87 and 3.19.

Tweenvest scores MAIA Biotechnology, Inc. across four factors: quality 42/100, value 38/100. Its strongest factor is quality.

MAIA price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$72.38M
Revenue (TTM)
—
P/E
—
EPS
-0.61
Dividend yield
—
Beta (5Y)
0.28
52-week high
$3.19
52-week low
$0.87
Avg volume (3M)
—
Shares outstanding
60.83M
Employees
13
Next earnings
—

About MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.

ISIN
US5526411021
Founded
2018
Listed since
Jul 28, 2022
Exchange
NYSE American LLC
Currency
USD
CompanyMarket capPriceDay
OS Therapies IncorporatedNYSEAM: OSTX$74.72M$1.620.00%
Gain Therapeutics, Inc.NasdaqGM: GANX$74.63M$1.62-5.56%
Gwo Xi Stem Cell Applied Technology Co. , LtdTPEX: 6704$74.40MNT$24.70+12.53%
Vaxcell-Bio Therapeutics Co., Ltd.KOSDAQ: A323990$74.00M₩4,285.00+1.78%
iBio, Inc.NasdaqCM: IBIO$72.35M$0.92-18.22%
Hofseth BioCare ASAOB: HBC$72.15MNkr1.36+2.26%
Libo Pharma Corp.TPEX: 7888$71.56MNT$30.30+2.89%
RenovoRx, Inc.NasdaqCM: RNXT$71.30M$1.33-15.82%

Browse every Biotechnology company →

Figures last refreshed Oct 4, 2026.